Tri Locum Partners’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$101M Sell
414,503
-188,640
-31% -$43.9M 14.22% 1
2025
Q4
$125M Buy
603,143
+300,312
+99% +$59.4M 16.21% 1
2025
Q3
$56.2M Buy
+302,831
New +$51.9M 12.91% 1
2023
Q3
Sell
-127,362
Closed -$21.1M 71
2023
Q2
$21.1M Buy
+127,362
New +$20.6M 7.83% 2
2021
Q3
Sell
-85,596
Closed -$14.1M 37
2021
Q2
$14.1M Sell
85,596
-83,038
-49% -$13.7M 4.62% 8
2021
Q1
$27.7M Buy
168,634
+6,001
+4% +$971K 6.87% 5
2020
Q4
$25.6M Buy
+162,633
New +$24M 9.3% 1

Other funds holding JNJ

Tri Locum Partners's JNJ Position: Q1 2026 in Review

Tri Locum Partners reduced its Johnson & Johnson (JNJ) stake by 31% in Q1 2026, selling an estimated $43.9M and leaving 414,503 shares worth $101M. The position accounts for 14.22% of the portfolio, ranked #1.

Tri Locum Partners first reported a position in JNJ in Q4 2020 and has held it in 7 quarters since. The position peaked at $125M in Q4 2025. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Tri Locum Partners held 414,503 shares of Johnson & Johnson worth $101M as of Q1 2026.
  • Tri Locum Partners sold 188,640 Johnson & Johnson shares in Q1 2026, an estimated $43.9M.
  • Johnson & Johnson made up 14.22% of Tri Locum Partners's portfolio in Q1 2026, its #1 holding.
  • Tri Locum Partners first reported a position in Johnson & Johnson in Q4 2020 and has held it in 7 quarters since.
  • Tri Locum Partners's Johnson & Johnson position peaked at $125M in Q4 2025.
  • 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Tri Locum Partners's 13F filing for Q1 2026, filed 18 May 2026.